This document discusses drug idiosyncrasy and adverse drug reactions. It defines drug idiosyncrasy as an abnormal genetic response to a drug in some individuals. Idiosyncratic reactions are non-dose related and unpredictable. The document categorizes and classifies different types of adverse drug reactions and discusses methods of detection, including pre-marketing clinical trials and post-marketing surveillance. It emphasizes the importance of reporting suspected adverse drug reactions to help prevent future harm.